YV BioMedconsult

Zaventem ·KBO/BCE: BE 0751.734.855

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	18-05-2026	74 d early	2026-00112609
31-12-2024	31-07-2025	25-04-2025	97 d early	2025-00075672
31-12-2023	31-07-2024	16-02-2024	166 d early	2024-00030959
31-12-2022	31-07-2023	16-08-2023	16 d late	2023-00329911

Metric	This company	Sector median	Position in the sector
Solvency	41.6%	71.4%	better than 28% of 46 sector peers
Net result	€29k	€4k	better than 74% of 46 sector peers
Equity	€34k	€137k	better than 28% of 46 sector peers
Gross operating margin	€137k	€135k	better than 50% of 46 sector peers
Staff costs	€62k	€234k	higher than 20% of 34 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€83k
Fixed assets	21/28	€36k
Tangible fixed assets	22/27	€36k
Financial fixed assets	28	€100
Current assets	29/58	€47k
Amounts receivable within one year	40/41	€10k
Cash & bank	54/58	€35k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€83k
Equity	10/15	€34k
Contributions / capital	10/11	€5k
Reserves	13	€29k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€48k
Amounts payable within one year	42/48	€48k
Trade debts payable within one year	44	€30k
Income statement
Gross operating margin	9900	€137k
Operating result	9901	€44k
Financial income	75	€0
Financial charges	65	€243
Result before taxes	9903	€44k
Income taxes	67/77	€14k
Net result for the period	9904	€29k
Result to be appropriated	9905	€29k

Summary